1. Home /
  2. Drug Approvals

Drug Approvals

2 Attractive Biotechs With Key Study Outcomes on the Horizon

2 Attractive Biotechs With Key Study Outcomes on the Horizon

Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.

Amarin Surges on Revenue Guidance Boost

Amarin Surges on Revenue Guidance Boost

Amarin surges after the pharmaceutical company boosts its revenue guidance amid strong demand for its Vascepa chronic cardiovascular treatment.

Bausch Health Gains on Debt Reduction, Psoriasis-Lotion Launch

Bausch Health Gains on Debt Reduction, Psoriasis-Lotion Launch

Bausch Health gain after key reduction in debt and rollout of new psoriasis treatment lotion.

IPO Gives Chinese Couple a 'Hansoh' Sum

IPO Gives Chinese Couple a 'Hansoh' Sum

The initial public offering of Hansoh Pharmaceutical Group made the Chinese couple Zhong Huijuan and Sun Piaoyang the richest in the nation.

Jim Cramer: A Tale of Two Stocks

Jim Cramer: A Tale of Two Stocks

I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.

2 Small Biotechs With Sagging Shares but Promising Prospects

2 Small Biotechs With Sagging Shares but Promising Prospects

The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.

Buy Stocks at a Big Discount With These 7 Closed-End Funds

Buy Stocks at a Big Discount With These 7 Closed-End Funds

Closed-end funds provide several benefits to investors over mutual funds.

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly's plan to eliminate pain could have farther reaching positive effects than just migraines.

Watch These 9 Companies in a Botox Export Boom Out of South Korea

Watch These 9 Companies in a Botox Export Boom Out of South Korea

South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.

Amgen Shares Gain on Positive Lung-Cancer Trial Results

Amgen Shares Gain on Positive Lung-Cancer Trial Results

Shares of Amgen rise after the company announces positive initial trial results from its experimental drug used to treat non-small-cell lung cancer patients.